Functional effects of glucose transporters in human ventricular myocardium (Q43190669)

15 November 2017

Functional effects of glucose transporters in human ventricular myocardium (English)

1 reference

15 November 2017

11

Burkert Pieske

1 reference

15 November 2017

Dirk von Lewinski

1

1 reference

15 November 2017

Robert Gasser

2

1 reference

15 November 2017

Peter P Rainer

3

1 reference

15 November 2017

Marie-Sophie Huber

4

1 reference

15 November 2017

Bastian Wilhelm

5

1 reference

15 November 2017

Ulrich Roessl

6

1 reference

15 November 2017

Tobias Haas

7

1 reference

15 November 2017

Andrae Wasler

8

1 reference

15 November 2017

Michael Grimm

9

1 reference

15 November 2017

Egbert Bisping

10

1 reference

15 November 2017

1 February 2010

1 reference

European Journal of Heart Failure

15 November 2017

1 reference

15 November 2017

12

1 reference

15 November 2017

106-113

1 reference

15 November 2017

2

1 reference

Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.

15 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Influence of perfusate calcium concentration on the inotropic insulin effect in isolated guinea pig and rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Metabolic gene expression in fetal and failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Myocardial substrate metabolism in the normal and failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Energy metabolism in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Glycolysis and pyruvate oxidation in cardiac hypertrophy--why so unbalanced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Atrial myocardium is the predominant inotropic target of adrenomedullin in the human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Expression of constitutively active Akt/protein kinase B signals GLUT4 translocation in the absence of an intact actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

Intravenous insulin has no effect on myocardial contractility or heart rate in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP191

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFP191

1 reference

15 November 2017

1 reference